Search filters

List of works by Anjali Joshi

Altered bystander apoptosis induction and pathogenesis of enfuvirtide-resistant HIV type 1 Env mutants

scientific article published on August 2009

Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors

scientific article published on 08 April 2019

Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay

scientific article

CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis.

scientific article

Capsid containing virus like particle vaccine against Zika virus made from a stable cell line

scientific article published on 10 October 2019

Cardiovascular complications of HIV infection and treatment

scientific article published on March 2013

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification

scientific article published on 22 January 2016

Defects in cellular sorting and retroviral assembly induced by GGA overexpression

scientific article

Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus

scientific article published on 09 August 2017

Different thresholds of T cell activation regulate FIV infection of CD4+CD25+ and CD4+CD25- cells

scientific article published in May 2005

Differential Pathogenicity of SHIV KB9 and 89.6 Env Correlates with Bystander Apoptosis Induction in CD4+ T cells

scientific article published on 01 October 2019

Enhancement of Zika virus infection by antibodies from West Nile virus seropositive individuals with no history of clinical infection

scientific article published on 09 January 2021

Evidence of a Role for Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE) Machinery in HIV-1 Assembly and Release ⬇️

scientific article published on June 16, 2011

Evidence of a role for soluble -ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release

scientific article published in 2014

Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment

scientific article published on 18 March 2009

Feline immunodeficiency virus envelope glycoprotein mediates apoptosis in activated PBMC by a mechanism dependent on gp41 function

scientific article published in December 2004

Functional replacement of a retroviral late domain by ubiquitin fusion

scientific article published on 09 August 2008

GGA and Arf proteins modulate retrovirus assembly and release

scientific article published on April 2008

Genetic signatures of HIV-1 envelope-mediated bystander apoptosis

scientific article

HIV ENV Glycoprotein-mediated Bystander Apoptosis Depends on Expression of the CCR5 Co-receptor at the Cell Surface and ENV Fusogenic Activity ⬇️

scientific article published on August 22, 2011

HIV-1 Env Glycoprotein Phenotype along with Immune Activation Determines CD4 T Cell Loss in HIV Patients

scientific article published on 13 January 2016

HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc

scientific article published on 24 March 2016

HIV-1 induced bystander apoptosis

scientific article

HIV-1 subtype CRF01_AE and B differ in utilization of low levels of CCR5, Maraviroc susceptibility and potential N-glycosylation sites

scientific article published on 8 October 2017

Host and Viral Factors in HIV-Mediated Bystander Apoptosis

scientific article

Identification of conserved motifs in the West Nile virus envelope essential for particle secretion

scientific article

Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation

scientific article

Point Mutations in the HIV-1 Matrix Protein Turn Off the Myristyl Switch

scientific article

Preferential feline immunodeficiency virus (FIV) infection of CD4+ CD25+ T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factors

scientific article

Preferential replication of FIV in activated CD4(+)CD25(+)T cells independent of cellular proliferation

scientific article published in April 2004

Primary cutaneous cryptococcosis treated with debridement and fluconazole monotherapy in an immunosuppressed patient: a case report and review of the literature

scientific article

Recent Advances in Zika Virus Vaccines

scholarly article by Himanshu Garg et al published 14 November 2018 in Viruses

SNAREs in HIV-1 assembly ⬇️

scientific article published on March 1, 2012

Single amino acid change in gp41 region of HIV-1 alters bystander apoptosis and CD4 decline in humanized mice ⬇️

scientific article published on January 21, 2011

Site-specific Mutations in HIV-1 gp41 Reveal a Correlation between HIV-1-mediated Bystander Apoptosis and Fusion/Hemifusion

scientific article published in Journal of Biological Chemistry

Strategies for targeted nonviral delivery of siRNAs in vivo

scientific article published on 19 October 2009

Structural basis for viral late-domain binding to Alix

scientific article

Synthesis and anti-tumor activity of carbohydrate analogues of the tetrahydrofuran containing acetogenins

scientific article published on 29 August 2013

Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides ⬇️

scientific article published on August 15, 2011

TCR‐induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56lck residues ⬇️

scientific article published on June 6, 2012

TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients

scientific article published on 16 January 2019

Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy ⬇️

scientific article published on May 6, 2011

Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus

scientific article published on 04 March 2020

Paulina is supported by:

About Paulina

Help